Long-Term Safety and Efficacy of Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

被引：26

作者：

Short, Nicholas J. ^{[1
]}

Kantarjian, Hagop M. ^{[2
]}

Ravandi, Farhad ^{[2
]}

Huang, Xuelin ^{[3
]}

Daver, Naval G. ^{[2
]}

DiNardo, Courtney D. ^{[2
]}

Konopleva, Marina Y. ^{[4
]}

Pemmaraju, Naveen ^{[2
]}

Wierda, William G. ^{[2
]}

Garcia-Manero, Guillermo ^{[2
]}

Sasaki, Koji ^{[5
]}

Cortes, Jorge E. ^{[2
]}

Garris, Rebecca ^{[2
]}

Ward, Marygrace ^{[2
]}

Huang, Binru ^{[5
]}

Encarnacion, Corabelle ^{[5
]}

Loiselle, Christopher ^{[5
]}

Khoury, Joseph D. ^{[6
]}

Jorgensen, Jeffrey L. ^{[6
]}

Jain, Nitin ^{[2
]}

Alvarez, Joie ^{[2
]}

Tippett, Nicole ^{[2
]}

O'Brien, Susan M. ^{[7
]}

Jabbour, Elias ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA

[5] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[7] Univ Calif Irvine Hlth, Div Hematol Oncol, Dept Med, Chao Family Comprehens Canc Ctr, Orange, CA USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-125146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

283

引用

页数：6

共 50 条

[1] Hyper-CVAD Plus Ponatinib Versus Hyper-CVAD Plus Dasatinib as Frontline Therapy for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis
Sasaki, Koji
Jabbour, Elias J.
Ravandi, Farhad
Short, Nicholas J.
Thomas, Deborah A.
Garcia-Manero, Guillermo
Daver, Naval G.
Kadia, Tapan M.
Konopleva, Marina Y.
Jain, Nitin
Issa, Ghayas C.
Jeanis, Vicki
Moore, Haim G.
Garris, Rebecca S.
Pemmaraju, Naveen
Cortes, Jorge E.
O'Brien, Susan M.
Kantarjian, Hagop M.
CANCER, 2016, 122 (23) : 3650 - 3656
[2] UPDATED RESULTS OF A PHASE II STUDY OF HYPER-CVAD PLUS PONATINIB AS FRONTLINE THERAPY FOR ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Short, N.
Kantarjian, H.
Ravandi, F.
Daver, N.
Pemmaraju, N.
Thomas, D.
Yilmaz, M.
Kadia, T.
Sasaki, K.
Garris, R.
Garcia-Manero, G.
DiNardo, C.
Konopleva, M.
Estrov, Z.
Jain, N.
Wierda, W.
Jeanis, V.
Cortes, J.
O'Brien, S.
Jabbour, E.
HAEMATOLOGICA, 2017, 102 : 198 - 198
[3] A Comprehensive Cancer Center Experience with Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Othman, Tamer
Moskoff, Benjamin
Tenold, Matthew
Azenkot, Tali
Krackeler, Margaret
Fisch, Samantha C.
Potter, Laura A.
Kaesberg, Paul R.
Welborn, Jeanna
Wun, Ted
Esteghamat, Naseem
Hoeg, Rasmus T.
Rosenberg, Aaron S.
Abedi, Mehrdad
Tuscano, Joseph
Jonas, Brian A.
BLOOD, 2021, 138
[4] Hyper-CVAD Plus Ponatinib as Frontline Therapy in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase II Trial
Maiti, Abhishek
Kantarjian, Hagop
Ravandi, Farhad
Short, Nicholas
Daver, Naval
Pemmaraju, Naveen
Thomas, Deborah
Yilmaz, Musa
Kadia, Tapan
Sasaki, Koji
Garris, Rebecca
Garcia-Manero, Guillermo
DiNardo, Courtney
Konopleva, Marina
Estrov, Zeev
Jain, Nitin
Weirda, William
Jeanis, Vicky
Cortes, Jorge
O'Brien, Susan
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S257 - S258
[5] Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib
Sasaki, Yuya
Kantarjian, Hagop M.
Short, Nicholas J.
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Wang, Feng
Furudate, Ken
Garris, Rebecca
Takahashi, Koichi
Jabbour, Elias
BLOOD, 2020, 136
[6] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Yuya Sasaki
Hagop M. Kantarjian
Nicholas J. Short
Feng Wang
Ken Furudate
Hidetaka Uryu
Rebecca Garris
Nitin Jain
Koji Sasaki
Farhad Ravandi
Marina Konopleva
Guillermo Garcia-Manero
Latasha Little
Curtis Gumbs
Li Zhao
P. Andrew Futreal
Koichi Takahashi
Elias Jabbour
Leukemia, 2022, 36 : 1253 - 1260
[7] Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Sasaki, Yuya
Kantarjian, Hagop M.
Short, Nicholas J.
Wang, Feng
Furudate, Ken
Uryu, Hidetaka
Garris, Rebecca
Jain, Nitin
Sasaki, Koji
Ravandi, Farhad
Konopleva, Marina
Garcia-Manero, Guillermo
Little, Latasha
Gumbs, Curtis
Zhao, Li
Futreal, P. Andrew
Takahashi, Koichi
Jabbour, Elias
LEUKEMIA, 2022, 36 (05) : 1253 - 1260
[8] Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Yuya Sasaki
Hagop M. Kantarjian
Nicholas J. Short
Feng Wang
Ken Furudate
Hidetaka Uryu
Rebecca Garris
Nitin Jain
Koji Sasaki
Farhad Ravandi
Marina Konopleva
Guillermo Garcia-Manero
Latasha Little
Curtis Gumbs
Li Zhao
P. Andrew Futreal
Koichi Takahashi
Elias Jabbour
Leukemia, 2022, 36 : 1448 - 1448
[9] Phase II Study of the Frontline Hyper-CVAD in Combination with Ponatinib for Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sasaki, Koji
Jabbour, Elias J.
Ravandi, Farhad
Daver, Naval G.
Pemmaraju, Naveen
Thomas, Deborah A.
Khouri, Rita B.
Yilmaz, Musa
Kadia, Tapan M.
Short, Nicholas J.
Garris, Rebecca
Garcia-Manero, Guillermo
DiNardo, Courtney D.
Konopleva, Marina
Estrov, Zeev
Jain, Nitin
Wierda, William G.
Jeanis, Twilla Victoria
Cortes, Jorge E.
O'Brien, Susan M.
Kantarjian, Hagop M.
BLOOD, 2016, 128 (22)
[10] Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results
Kantarjian, Hagop
Short, Nicholas J.
Jain, Nitin
Sasaki, Koji
Huang, Xuelin
Haddad, Fadi G.
Khouri, Issa
DiNardo, Courtney D.
Pemmaraju, Naveen
Wierda, William
Garcia-Manero, Guillermo
Kebriaei, Partow
Garris, Rebecca
Loghavi, Sanam
Jorgensen, Jeffrey
Kwari, Monica
O'Brien, Susan
Ravandi, Farhad
Jabbour, Elias
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (03) : 493 - 501

← 1 2 3 4 5 →